Blogging Course San Diego Technical Review 
Xconomy
JUNE 24, 2019
These can be positive attributes in an entrepreneur, but in a more rational world, technology investors wouldn’t overvalue them. In the real world, of course, proof is hard to come by. Risk capital would be allocated based mostly on evidence, data, progress towards milestones—in short, on proof.
Both Sides of the Table
OCTOBER 19, 2009
On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
DECEMBER 6, 2013
Every year my family meets in San Diego for Thanksgiving. Panic ensued as we couldn’t bring the dogs to San Diego and my brother’s three kids look forward to this great trip all year. They can read reviews, see pictures and even talk to the family before confirming. The Background. “Oh s**t.”
Xconomy
SEPTEMBER 2, 2016
Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson.
Xconomy
OCTOBER 5, 2016
The first round of pitches are due this week. “DARPA is saying you can’t retrofit [biosafety] into existing technology, you have to design it—not just into widgets and technologies, but into the institutions that are supporting the technologies.”
Xconomy
AUGUST 12, 2016
government’s Precision Medicine Initiative is an ambitious effort to collect the genomic data of 1 million Americans, and tech giant Alphabet (NASDAQ: GOOG ) is deeply involved. That story and the rest of the week’s biotech headlines below. —The U.S. —David H. In the U.S.,
Xconomy
JULY 1, 2016
To boost the initiative, which aims to speed the pace of cancer research, FDA said it would consolidate its cancer review divisions under the Oncology Center of Excellence. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. .
Expert insights. Personalized for you.
107 
Let's personalize your content